NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
TORONTO, July 31, 2020 (GLOBE NEWSWIRE) -- QuestCap Inc. (“QuestCap” or the “Company”) (CSE:QSC; FRA:34C1) is pleased to announce the use of Glenco’s Standard for Safe Sets (the “Standard”) by Pilgrim Media Group, a Lionsgate company based in North Hollywood, CA. In June, QuestCap acquired a 30% ownership in Glenco.
The Standard was adopted from standards and protocols originally developed for the professional and amateur sport’s industries entitled “The Standard for Safe Sports™” prepared by Glenco. This Standard has been presented to members of the NBA, MLB, CFL and the Dimayor league of Colombia.
“Your services have been very production friendly,” says Ms. Jeanette Gardzelewski, Line Producer for Pilgrim Media Group, a Lionsgate Company based in North Hollywood, California. “Implementing your Standards for a safer film set have in line with our needs, flexible with our busy, ever-changing production schedule and informative with testing details,” says Ms. Gardzelewski.
“We are equally concerned and committed to restoring the film industry’s production and financial performance,” stated Mr. Doug Sommerville, the CEO of QuestCap Inc. “It is not a sound financial model for all the stakeholders to simply idle for months on end, with no end in sight. But it is equally important to ensure we don’t rush onto sets without the care and concern for one another’s health and well-being. This is precisely why our standards work - resuming production without compromising people’s health,” concludes Mr. Sommerville.
Lionsgate Films (formerly known as Cinépix Film Properties) is an American film production and film distribution studio, headquartered in Santa Monica and founded in Canada, and is the flagship division of Lionsgate Entertainment. It is the largest and most successful mini-major film studio in North America. It focuses on foreign and independent films and has distributed various commercially successful film series, including The Hunger Games, Rambo, Divergent, The Punisher (prior to Marvel Studios acquiring its rights back in 2013), John Wick, Saw, Madea, Blair Witch, Now You See Me, Hostel, The Expendables, Sinister, The Twilight Saga and Step Up (both partially, via the firm's 2012 acquisition of two series' distributor Summit Entertainment. The latter was distributed by Disney's Touchstone Pictures since its first film).
“Embracing the Standard allowed us to understand better and so to navigate our international travel and production needs, we appreciate how helpful the firm has been at guiding us through the testing processes for each different situation, location and myriad of ever-evolving needs,” concludes Ms. Gardzelewski.
About QuestCap Inc.
QuestCap Inc. (CSE:QSC; FRA:34C1) is a social-impact investment company. Through QuestCap’s three divisions, MedQuest, TechQuest and ClimateQuest, it seeks, secures and funds recognized sciences, technologies, and solutions that impact our global community today.
The QuestCap executive team is complemented by a panel of global advisors that provide expertise across industries and geographies. This panel includes prominent immunologist Dr. Lawrence Steinman and Dr. Glenn Copeland, who has 45 years of experience in orthopedic treatment, foot and ankle care, and sports medicine.
Recent MedQuest investments in addition to Glenco include: $1M into Sunnybrook Hospital’s Research Group for Emerging and Respiratory Viruses (such amount payable in equal $250,000 installments) and $0.5M into Sinai Health Foundation’s research in COVID-19 diagnostic testing (such amount payable in equal $125,000 installments).
QuestCap provides financing for a diverse range of entities in exchange for pre-determined royalties or distributions, or acquires all or part of one or more businesses, portfolios or other assets.
For additional information, please contact:
Doug Sommerville, CEO
doug.sommerville@questcapinc.com
416-301-5418
For Canadian media enquires please contact:
Evan Veryard
evan.veryard@questcapinc.com
For US media enquires please contact:
Veronica Welch
veronica@vewprmedia.com
+1-508-643-8000
Cautionary Note Regarding Forward-looking Information
This press release contains "forward-looking information" within the meaning of applicable Canadian securities legislation. Forward-looking information includes, but is not limited to, statements with respect to the use of the Standard; the pursuit by QuestCap of investment opportunities; and the merits or potential returns of any such investments. Generally, forward-looking information can be identified by the use of forward-looking terminology such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might" or "will be taken", "occur" or "be achieved". Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company, as the case may be, to be materially different from those expressed or implied by such forward-looking information. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking information. The Company does not undertake to update any forward-looking information, except in accordance with applicable securities laws.
NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATION SERVICES PROVIDER HAS REVIEWED OR ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
